Literature DB >> 16278527

Pharmacotherapy review: Angiotensin receptor antagonists.

Domenic A Sica1.   

Abstract

Angiotensin receptor blockers are one of several drug classes that act by interfering with activity of the renin-angiotensin axis. Drugs in this class are as effective as angiotensin-converting enzyme inhibitors in the reduction of blood pressure in hypertensive patients. Results from a series of outcomes trials increasingly support the use of drugs in this class as cardioprotective and renoprotective agents in patients with heart failure, diabetic nephropathy, and post-myocardial infarction.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16278527      PMCID： PMC8109488          DOI： 10.1111/j.1524-6175.2005.04135.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


  6 in total

1.  Comparative angiotensin II receptor blockade in healthy volunteers: the importance of dosing.

Authors:  Marc P Maillard; Grégoire Würzner; Jürg Nussberger; Catherine Centeno; Michel Burnier; Hans R Brunner
Journal:  Clin Pharmacol Ther       Date:  2002-01       Impact factor: 6.875

2.  Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.

Authors:  Hussam Abuissa; Philip G Jones; Steven P Marso; James H O'Keefe
Journal:  J Am Coll Cardiol       Date:  2005-09-06       Impact factor: 24.094

Review 3.  Therapeutic trials comparing angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.

Authors:  W J Elliott
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

4.  Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.

Authors:  Fiona Turnbull; Bruce Neal; Charles Algert; John Chalmers; Neil Chapman; Jeff Cutler; Mark Woodward; Stephen MacMahon
Journal:  Arch Intern Med       Date:  2005-06-27

5.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 6.  Combination therapy in the management of hypertension: focus on angiotensin receptor blockers combined with diuretics.

Authors:  Paolo Palatini
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-02       Impact factor: 3.738
  6 in total
  2 in total

Review 1.  Combination ACE inhibitor and angiotensin receptor blocker therapy - future considerations.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-01       Impact factor: 3.738

Review 2.  Angiotensin receptor blockers: new considerations in their mechanism of action.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-05       Impact factor: 3.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.